Article
Atrial Septal Defect Device Closure in Patients with Metabolic Diseases or Genetic Syndromes
2021-12-09
Abstract excerpt
Concomitant metabolic or genetic syndromes can make atrial septal defect device closure difficult. We searched our database and found eight. The cohort consists of patients with different metabolic and genetic disease . Thromboembolic events and device embolization occurred in some patients. Careful attention is recommended in patients with special diseases.
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 43b2234f-b974-549e-926e-dd52fba0c8fb
- DOI
- 10.22541/au.163907167.75800562/v1
